Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Wanner

Showing results (461-470 of 666) with videos related to

Pageof 67
Sort By:
Journal of the American College of Cardiology|September 24, 2021
Empagliflozin Improves Cardiovascular and Renal Outcomes in Heart Failure Irrespective of Systolic Blood PressureMichael Böhm, Stefan D Anker, Javed Butler, et al.
Clinical Kidney Journal|August 25, 2022
Expert guidance on the multidisciplinary management of cystinosis in adolescent and adult patientsElena Levtchenko, Aude Servais, Sally A Hulton, et al.
JAMA Cardiology|June 14, 2023
Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With FinerenoneRajiv Agarwal, Bertram Pitt, Peter Rossing, et al.
Clinical Kidney Journal|November 12, 2025
Dosing, treatment patterns and safety of finerenone use in routine care: an interim analysis of the prospective, real-world and observational FINE-REAL studyDavid C Wheeler, Kevin M Pantalone, Lixin Guo, et al.
Journal of the American College of Cardiology|June 30, 2022
Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of AgeMichael Böhm, Javed Butler, Gerasimos Filippatos, et al.
Circulation|July 15, 2024
Loss of Y Chromosome and Cardiovascular Events in Chronic Kidney DiseaseMichael Weyrich, Sebastian Cremer, Martin Gerster, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 19, 2006
Fabry disease: guidelines for the evaluation and management of multi-organ system involvementChristine M Eng, Dominique P Germain, Maryam Banikazemi, et al.
Kidney Medicine|January 1, 2024
Protein Biomarkers and Major Cardiovascular Events in Older People With Advanced CKD: The European Quality (EQUAL) StudySamantha J L Hayward, Nicholas C Chesnaye, Barnaby Hole, et al.
BMC Medical Research Methodology|February 12, 2022
Converting from face-to-face to postal follow-up and its effects on participant retention, response rates and errors: lessons from the EQUAL study in the UKEmer Gates, Barnaby Hole, Samantha Hayward, et al.
Advances in Therapy|September 23, 2025
A Strategic Roadmap to Support Communication on and Acceptance of Surrogate Endpoints: The REnal Surrogacy accEpTance in Chronic Kidney Disease (RESET CKD) CollaborationJuan José Garcia Sanchez, Marta Trapero-Bertran, Oriana Ciani, et al.
Pageof 67

Showing results (461-470 of 666) with videos related to

Sort By:
Pageof 67
Journal of the American College of Cardiology|September 24, 2021
Empagliflozin Improves Cardiovascular and Renal Outcomes in Heart Failure Irrespective of Systolic Blood PressureMichael Böhm, Stefan D Anker, Javed Butler, et al.
Clinical Kidney Journal|August 25, 2022
Expert guidance on the multidisciplinary management of cystinosis in adolescent and adult patientsElena Levtchenko, Aude Servais, Sally A Hulton, et al.
JAMA Cardiology|June 14, 2023
Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With FinerenoneRajiv Agarwal, Bertram Pitt, Peter Rossing, et al.
Clinical Kidney Journal|November 12, 2025
Dosing, treatment patterns and safety of finerenone use in routine care: an interim analysis of the prospective, real-world and observational FINE-REAL studyDavid C Wheeler, Kevin M Pantalone, Lixin Guo, et al.
Journal of the American College of Cardiology|June 30, 2022
Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of AgeMichael Böhm, Javed Butler, Gerasimos Filippatos, et al.
Circulation|July 15, 2024
Loss of Y Chromosome and Cardiovascular Events in Chronic Kidney DiseaseMichael Weyrich, Sebastian Cremer, Martin Gerster, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 19, 2006
Fabry disease: guidelines for the evaluation and management of multi-organ system involvementChristine M Eng, Dominique P Germain, Maryam Banikazemi, et al.
Kidney Medicine|January 1, 2024
Protein Biomarkers and Major Cardiovascular Events in Older People With Advanced CKD: The European Quality (EQUAL) StudySamantha J L Hayward, Nicholas C Chesnaye, Barnaby Hole, et al.
BMC Medical Research Methodology|February 12, 2022
Converting from face-to-face to postal follow-up and its effects on participant retention, response rates and errors: lessons from the EQUAL study in the UKEmer Gates, Barnaby Hole, Samantha Hayward, et al.
Advances in Therapy|September 23, 2025
A Strategic Roadmap to Support Communication on and Acceptance of Surrogate Endpoints: The REnal Surrogacy accEpTance in Chronic Kidney Disease (RESET CKD) CollaborationJuan José Garcia Sanchez, Marta Trapero-Bertran, Oriana Ciani, et al.
Pageof 67